The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease
Abstract
CONTEXT: The projected expansion in the next several decades of the elderly population at highest risk for Parkinson disease (PD) makes identification of factors that promote or prevent the disease an important goal. OBJECTIVE: To explore the association of coffee and dietary caffeine intake with risk of PD. DESIGN, SETTING, AND PARTICIPANTS: Data were analyzed from 30 years of follow-up of 8004 Japanese-American men (aged 45-68 years) enrolled in the prospective longitudinal Honolulu Heart Program between 1965 and 1968. MAIN OUTCOME MEASURE: Incident PD, by amount of coffee intake (measured at study enrollment and 6-year follow-up) and by total dietary caffeine intake (measured at enrollment). RESULTS: During follow-up, 102 men were identified as having PD. Age-adjusted incidence of PD declined consistently with increased amounts of coffee intake, from 10.4 per 10,000 person-years in men who drank no coffee to 1.9 per 10,000 person-years in men who drank at least 28 oz/d (P<.001 for trend). Similar relationships were observed with total caffeine intake (P<.001 for trend) and caffeine from non-coffee sources (P=.03 for trend). Consumption of increasing amounts of coffee was also associated with lower risk of PD in men who were never, past, and current smokers at baseline (P=.049, P=.22, and P=.02, respectively, for trend). Other nutrients in coffee, including niacin, were unrelated to PD incidence. The relationship between caffeine and PD was unaltered by intake of milk and sugar. CONCLUSIONS: Our findings indicate that higher coffee and caffeine intake is associated with a significantly lower incidence of PD. This effect appears to be independent of smoking. The data suggest that the mechanism is related to caffeine intake and not to other nutrients contained in coffee. JAMA. 2000;283:2674-2679.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For women, there is a U-shaped relationship between coffee consumption and Parkinson’s disease risk, with women drinking 1–3 cups of coffee per day having the lowest risk.”
From Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human (2020) · cites this paper as [110]
In the citing paper
“An inverse association between coffee consumption and PD risk has been found in several epidemiological studies [110,121,122,123].”
From Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human (2020) · cites this paper as [110]
In the citing paper
“A study by Ascherio et al. reported that men who consumed a moderate amount of coffee had a significantly lower risk of PD than men who did not drink coffee at all [110].”
From Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human (2020) · cites this paper as [110]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,072
Nehlig, A., Daval, J., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,463
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R. P., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 876
Epidemiology of parkinson’s disease
Tanner, C. M., & Goldman, S. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70259-0 · Cited by 640
Coffee, Alcohol and Risk of Coronary Heart Disease among Japanese Men Living in Hawaii
Yano, K., Rhoads, G. G., & Kagan, A. (1977) · New England Journal of Medicine · doi:10.1056/nejm197708252970801 · Cited by 524
Prevalence of Dementia in Older Japanese-American Men in Hawaii: The Honolulu-Asia Aging Study
White, L. (1996) · JAMA · doi:10.1001/jama.1996.03540120033030 · Cited by 437
TEN-YEAR INCIDENCE OF CORONARY HEART DISEASE IN THE HONOLULU HEART PROGRAM
Yano, K., REED, D. M., & McGee, D. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113787 · Cited by 370
Worldwide Occurrence of Parkinson's Disease: An Updated Review
Zhang, Z., & Román, G. C. (1993) · Neuroepidemiology · doi:10.1159/000110318 · Cited by 332
Analysis of Covariance and Standardization as Instances of Prediction
Lane, P. W., & Nelder, J. A. (1982) · Biometrics · doi:10.2307/2530043 · Cited by 311
Research diagnostic criteria for Parkinson's disease.
Ward, C. D., & Gibb, W. R. G. (1990) · PubMed · Cited by 265
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
Richardson, P. J., Kase, H., & Jenner, P. G. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01096-1 · Cited by 262
Worth, R. M., & Kagan, A. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90022-6 · Cited by 238
Assessment of Parkinsonʼs Disease
Larsen, T., Calne, S. M., & Calne, D. B. (1984) · Clinical Neuropharmacology · doi:10.1097/00002826-198406000-00008 · Cited by 230
Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome
Trenkwalder, C., Hening, W. A., Walters, A. S., Campbell, S. S., Rahman, K., & Chokroverty, S. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1 · Cited by 226
Prospective Study of Cigarette Smoking and the Risk of Developing Idiopathic Parkinson's Disease
Grandinetti, A., Morens, D. M., REED, D. M., & MacEachern, D. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116960 · Cited by 221
Diet and Parkinson's disease II
Hellenbrand, W., Boeing, H., Robra, B., Seidler, A., Vieregge, P., NISCHAN, P., Joerg, J., Oertel, W. H., Schneider, E., & Ulm, G. (1996) · Neurology · doi:10.1212/wnl.47.3.644 · Cited by 195
Epidemiologic observations on Parkinson's disease
Morens, D. M., Davis, J. W., Grandinetti, A., Ross, G. W., Popper, J. S., & White, L. R. (1996) · Neurology · doi:10.1212/wnl.46.4.1044 · Cited by 183
Self-citationEpidemiology versus genetics in parkinson's disease: Progress in resolving an age‐old debate
Langston, J. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440707 · Cited by 165
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
Richardson, P. J., Kase, H., & Jenner, P. G. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90660-x · Cited by 136
Epidemiology of Parkinson’s Disease
Tanner, C. M. (1992) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30212-3 · Cited by 135
A RETROSPECTIVE STUDY OF SMOKING IN PARKINSON'S DISEASE1
Nefzger, M. D., QUADFASEL, F. A., & KARL, V. C. (1968) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120874 · Cited by 130
Jiméanez‐Jiméanez, F. J., Mateo, D., & Giméanez‐Roldan, S. (1992) · Movement Disorders · doi:10.1002/mds.870070407 · Cited by 102
Adenosine A2A receptors modify motor function in MPTP-treated common marmosets
Kanda, T., Tashiro, T., Kuwana, Y., & Jenner, P. G. (1998) · Neuroreport · doi:10.1097/00001756-199808240-00032 · Cited by 102
Within-person variability of nutrient intake in a group of Hawaiian men of Japanese ancestry
McGee, D., Rhoads, G. G., Hankin, J. H., Yano, K., & TILLOTSON, J. L. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.4.657 · Cited by 82
Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study
White, L. R. (1996) · JAMA · doi:10.1001/jama.276.12.955 · Cited by 76
The effect of theophylline on parkinsonian symptoms
Málly, J., & Stone, T. W. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03840.x · Cited by 69
Heilbrun, L. K., Kagan, A., Nomura, A., & Rd, W. (1985) · PubMed · Cited by 51
COFFEE, CAFFEINE, AND SERUM CHOLESTEROL IN JAPANESE MEN IN HAWAII
Curb, J. D., REED, D. M., Kautz, J. A., & Yano, K. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114284 · Cited by 50
Caffeine and the antiparkinsonian response to levodopa or piribedil
Shoulson, I., & Chase, T. N. (1975) · Neurology · doi:10.1212/wnl.25.8.722 · Cited by 47
Kartzinel, R., Shoulson, I., & Calne, D. B. (1976) · Neurology · doi:10.1212/wnl.26.8.741 · Cited by 44
Caffeine mimics dopamine receptor agonists without stimulation of dopamine receptors
Watanabe, H., & Uramoto, H. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90208-x · Cited by 43
Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii
Kaye, B. L. (1978) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-197804000-00125 · Cited by 30
Popoli, P., Caporali, M. G., & de Carolis, A. S. (1991) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1991.tb06685.x · Cited by 26
Cited by
Sorted by citations
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
The epidemiology of Parkinson's disease: risk factors and prevention
Ascherio, A., & Schwarzschild, M. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30230-7 · Cited by 1,930
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431
Samii, A., Nutt, J. G., & Ransom, B. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16305-8 · Cited by 1,361
Metadata
- Authors
- Ross, G. W.
- Affiliations
- United States Department of Veterans Affairs (US)
- Corresponding author
- Ross, G. Webster
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2000-05-24
- Volume
- 283
- Issue
- 20
- Pages
- 2674
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2128822428
- Cited by
- 778
- References
- 35
- Citations by year
- 2026: 8 · 2025: 24 · 2024: 28 · 2023: 34 · 2022: 22 · 2021: 39 · 2020: 26 · 2019: 35 · 2018: 26 · 2017: 36 · 2016: 24 · 2015: 29 · 2014: 39 · 2013: 37 · 2012: 36
- FWCI
- 17.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc005102-027, DAMD17-98-1-8621)
- National Institute on Aging (N01‐AG‐4‐2149)
- National Heart, Lung, and Blood Institute (N01 HC 05102, NO1-HC-05102)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, coffee consumption, dietary caffeine, caffeine consumption, smoking, nicotinic acid, Honolulu Heart Program, Japanese-American men, disease incidence
- MeSH terms
- Aged, Caffeine, Coffee, Diet Surveys, Humans, Longitudinal Studies, Male, Middle Aged, Parkinson Disease, Regression Analysis, Risk Factors, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review